Marie Thibault Analyst PerformanceManaging Director at BTIG ResearchMarie Thibault is a stock analyst at BTIG Research focused in the medical sector, covering 26 publicly traded companies. Over the past year, Marie Thibault has issued 62 stock ratings, including buy and hold recommendations. While full access to Marie Thibault's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Marie Thibault's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings110 Last 6 YearsBuy Recommendations88.89% 96 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution108RatingsDistribution of strong buy, buy, hold, and sell ratings by Marie Thibault.RatingPercentageCount Strong Buy0.0%0 ratings Buy88.9%96 ratings Hold11.1%12 ratings Sell0.0%0 ratingsOut of 108 total stock ratings issued by Marie Thibault at BTIG Research, the majority (88.9%) have been Buy recommendations, followed by 11.1% Hold.Best & Worst CallsBest Call0000.0%STIMMay 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%VAPOSep 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ80.8% of companies on NASDAQ21 companiesNYSE19.2% of companies on NYSE5 companiesMarie Thibault, an analyst at BTIG Research, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical22 companies84.6%Manufacturing2 companies7.7%Computer and Technology2 companies7.7%Marie Thibault of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS8 companies30.8%MED PRODUCTS7 companies26.9%MEDICAL SERVICES2 companies7.7%MEDICAL INFO SYS2 companies7.7%SURGICAL & MEDICAL INSTRUMENTS2 companies7.7%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company3.8%INTERNET SERVICES1 company3.8%MED - BIOMED/GENE1 company3.8%COMP - SOFTWARE1 company3.8%INDUSTRIAL MEASUREMENT INSTRUMENTS & RELATED PRODUCTS1 company3.8% About Marie ThibaultMarie Thibault is a Managing Director and BTIG Medical Technology and Digital Health Analyst. Prior to BTIG, Ms. Thibault was the Managing Editor of Medical Device & Diagnostics Industry, a trade publication covering medical technology. Earlier in her career, she was a Senior Associate within Medical Technology Equity Research at Lazard Capital Markets. Ms. Thibault earned a BS in biology with a minor in writing from the Massachusetts Institute of Technology and a master’s degree in business and economic reporting from New York University.Follow on LinkedIn Marie Thibault's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsARAYAccuray5/7/2026Downgrade$0.48Neutral$0.0000.00% ROIPODDInsulet5/6/2026Lower Price Target$148.55$260.00Buy$0.0000.00% ROIEMBCEmbecta5/5/2026Downgrade$3.90Neutral$0.0000.00% ROIHYPRHyperfine4/29/2026Initiated Coverage$1.30$2.00Buy$0.0000.00% ROIABTAbbott Laboratories4/27/2026Reiterated Rating$91.16$131.00Buy$0.0000.00% ROIEWEdwards Lifesciences4/24/2026Boost Price Target$79.69$100.00Buy$0.0000.00% ROIBSXBoston Scientific4/22/2026Lower Price Target$64.95$80.00Buy$0.0000.00% ROIABTAbbott Laboratories4/17/2026Reiterated Rating$95.08$131.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies4/7/2026Reiterated Rating$19.32$32.00Buy$0.0000.00% ROIMMEDMiniMed Group3/31/2026Initiated Coverage$14.35$25.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ABTAbbott Laboratories3/31/2026Lower Price Target$101.85$131.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies3/25/2026Reiterated Rating$20.70$32.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies3/18/2026Reiterated Rating$21.14$32.00Buy$0.0000.00% ROIDXCMDexCom3/9/2026Reiterated Rating$68.10$85.00Buy$0.0000.00% ROIDCTHDelcath Systems2/26/2026Lower Price Target$9.17$19.00Buy$0.0000.00% ROIDXCMDexCom2/25/2026Reiterated Rating$73.09$85.00Buy$0.0000.00% ROIMASIMasimo2/18/2026Downgrade$174.69Neutral$0.0000.00% ROIATRCAtriCure2/18/2026Reiterated Rating$32.97$54.00Buy$0.0000.00% ROIPODDInsulet2/18/2026Reiterated Rating$258.99$380.00Buy$0.0000.00% ROIABTAbbott Laboratories2/17/2026Lower Price Target$112.27$140.00Buy$0.0000.00% ROIDXCMDexCom2/13/2026Reiterated Rating$65.08$85.00Buy$0.0000.00% ROIOMOutset Medical2/12/2026Lower Price Target$4.54$15.00Buy$0.0000.00% ROIEWEdwards Lifesciences2/11/2026Reiterated Rating$77.00$103.00Buy$0.0000.00% ROIEMBCEmbecta2/6/2026Reiterated Rating$10.47$25.00Buy$0.0000.00% ROIHAEHaemonetics2/6/2026Reiterated Rating$65.00$88.00Buy$0.0000.00% ROIARAYAccuray2/5/2026Lower Price Target$0.76$2.00Buy$0.0000.00% ROIBSXBoston Scientific2/4/2026Reiterated Rating$75.50Buy$0.0000.00% ROIBSXBoston Scientific2/4/2026Lower Price Target$75.59$110.00Buy$0.0000.00% ROICBLLCeriBell1/28/2026Reiterated Rating$21.89$30.00Buy$0.0000.00% ROIABTAbbott Laboratories1/23/2026Lower Price Target$108.50$140.00Buy$0.0000.00% ROIHAEHaemonetics1/9/2026Reiterated Rating$84.05$88.00Buy$0.0000.00% ROIOMOutset Medical12/16/2025Reiterated Rating$3.97$17.00Buy$0.0000.00% ROICBLLCeriBell12/15/2025Reiterated Rating$20.93$30.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/4/2025Reiterated Rating$85.72$103.00Buy$0.0000.00% ROIMASIMasimo12/4/2025Boost Price Target$138.09$200.00Buy$0.0000.00% ROIEMBCEmbecta11/25/2025Reiterated Rating$13.90Buy$0.0000.00% ROIEWEdwards Lifesciences11/25/2025Reiterated Rating$84.70$100.00Buy$0.0000.00% ROIMASIMasimo11/24/2025Reiterated Rating$149.25$198.00Buy$0.0000.00% ROIHAEHaemonetics11/21/2025Reiterated Rating$75.08$88.00Buy$0.0000.00% ROIBSXBoston Scientific11/21/2025Reiterated Rating$96.63$132.00Buy$0.0000.00% ROIPODDInsulet11/21/2025Boost Price Target$312.89$380.00Buy$0.0000.00% ROIABTAbbott Laboratories11/20/2025Reiterated Rating$126.28$145.00Buy$0.0000.00% ROIKMTSKestra Medical Technologies11/18/2025Initiated Coverage$25.10$32.00Buy$0.0000.00% ROIPODDInsulet11/13/2025Reiterated Rating$336.84$370.00Buy$0.0000.00% ROIOMOutset Medical11/11/2025Lower Price Target$12.07$17.00Buy$0.0000.00% ROIPODDInsulet11/6/2025Reiterated Rating$323.40$370.00Buy$0.0000.00% ROIARAYAccuray11/6/2025Lower Price Target$1.45$4.00Buy$0.0000.00% ROIHAEHaemonetics11/6/2025Boost Price Target$65.50$88.00Buy$0.0000.00% ROIMASIMasimo11/5/2025Reiterated Rating$149.01$198.00Buy$0.0000.00% ROIDCTHDelcath Systems11/4/2025Reiterated Rating$8.94$23.00Buy$0.0000.00% ROIDXCMDexCom10/31/2025Lower Price Target$68.20$85.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/31/2025Boost Price Target$184.12$215.00Buy$0.0000.00% ROIBSXBoston Scientific10/22/2025Reiterated Rating$104.35$132.00Buy$0.0000.00% ROITRUETrueCar10/20/2025Downgrade$2.45Hold$0.0000.00% ROIABTAbbott Laboratories10/15/2025Reiterated Rating$129.35$145.00Buy$0.0000.00% ROIBSXBoston Scientific10/1/2025Boost Price Target$97.55$132.00Buy$0.0000.00% ROIBSXBoston Scientific9/23/2025Reiterated Rating$96.91$127.00Buy$0.0000.00% ROIMASIMasimo9/11/2025Reiterated Rating$145.82$198.00Buy$0.0000.00% ROIEMBCEmbecta9/5/2025Reiterated Rating$14.96$25.00Buy$0.0000.00% ROIOBIOOrchestra BioMed8/20/2025Reiterated Rating$2.55Neutral$0.0000.00% ROIABTAbbott Laboratories7/18/2025Lower Price Target$120.76$145.00Buy$0.0000.00% ROIOMOutset Medical7/14/2025Set Price Target$19.77$37.00Buy$0.0000.00% ROIMASIMasimo5/7/2025Set Price Target$150.11$193.00Buy$000.0000.00% ROIBSXBoston Scientific4/23/2025Reiterated Rating$99.01$124.00Buy$00.0000.00% ROIOBIOOrchestra BioMed3/20/2025Initiated Coverage$4.43$12.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
